CD44 is the signaling component of the macrophage migration inhibitory factor-CD74 receptor complex

被引:533
作者
Shi, Xuerong
Leng, Lin
Wang, Tian
Wang, Wenkui
Du, Xin
Li, Ji
McDonald, Courtney
Chen, Zun
Murphy, James W.
Lolis, Elias
Noble, Paul
Knudson, Warren
Bucala, Richard
机构
[1] Yale Univ, Sch Med, Dept Med, New Haven, CT 06520 USA
[2] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA
[3] Shanxi Agr Univ, Taigu, Peoples R China
[4] E Carolina Sch Med, Greenville, NC 27834 USA
关键词
D O I
10.1016/j.immuni.2006.08.020
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The macrophage migration inhibitory factor (MIF) receptor (CD74) was cloned recently, but the signaling mechanism is not evident. We hypothesized that signaling requires an additional molecule such as CD44, which activates nonreceptor tyrosine kinases. We utilized the CD74- and CD44-deficient CCS-7/M6 cell to create stable transfectants expressing CD74, CD44, and a truncated CD44 lacking its intracytoplasmic signaling domain. CD74 alone mediated MIF binding; however, MIF-induced ERK1 and ERK2 kinase phosphorylation required the coexpression of full-length CD44. MIF binding was associated with the serine phosphorylation of CD74 and CD44. Investigations that used siRNA or kinase inhibitors indicate that MIF-induced ERK1 and ERK2 activation through CD44 required the Src tyrosine kinase. Studies of CD74, CD44, and CD74-CD44 transformants and corresponding mutant cells showed that CD74 and CD44 were necessary for MIF protection from apoptosis. These data establish CD44 as an integral member of the CD74 receptor complex leading to MIF signal transduction.
引用
收藏
页码:595 / 606
页数:12
相关论文
共 65 条
[11]   A therapeutic future for CD44 in inflammation? [J].
Bradbury, J .
LANCET, 2002, 359 (9322) :2008-2008
[12]   MACROPHAGE IS AN IMPORTANT AND PREVIOUSLY UNRECOGNIZED SOURCE OF MACROPHAGE-MIGRATION INHIBITORY FACTOR [J].
CALANDRA, T ;
BERNHAGEN, J ;
MITCHELL, RA ;
BUCALA, R .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (06) :1895-1902
[13]   Macrophage migration inhibitory factor: A regulator of innate immunity [J].
Calandra, T ;
Roger, T .
NATURE REVIEWS IMMUNOLOGY, 2003, 3 (10) :791-800
[14]   Protection from septic shock by neutralization of macrophage migration inhibitory factor [J].
Calandra, T ;
Echtenacher, B ;
Le Roy, D ;
Pugin, J ;
Metz, CN ;
Hültner, L ;
Heumann, D ;
Männel, D ;
Bucala, R ;
Glauser, MP .
NATURE MEDICINE, 2000, 6 (02) :164-170
[15]   MIF AS A GLUCOCORTICOID-INDUCED MODULATOR OF CYTOKINE PRODUCTION [J].
CALANDRA, T ;
BERNHAGEN, J ;
METZ, CN ;
SPIEGEL, LA ;
BACHER, M ;
DONNELLY, T ;
CERAMI, A ;
BUCALA, R .
NATURE, 1995, 377 (6544) :68-71
[16]   CD44-deficient mice exhibit enhanced hepatitis after concanavalin a injection: Evidence for involvement of CD44 in activation-induced cell death [J].
Chen, DW ;
McKallip, RJ ;
Zeytun, A ;
Do, YK ;
Lombard, C ;
Robertson, JL ;
Mak, TW ;
Nagarkatti, PS ;
Nagarkatti, M .
JOURNAL OF IMMUNOLOGY, 2001, 166 (10) :5889-5897
[17]   SKI-606 decreases growth and motility of colorectal cancer cells by preventing pp60(c-Src)-dependent tyrosine phosphorylation of β-catenin and its nuclear signaling [J].
Coluccia, AML ;
Benati, D ;
Dekhil, H ;
De Filippo, A ;
Lan, C ;
Gambacorti-Passerini, C .
CANCER RESEARCH, 2006, 66 (04) :2279-2286
[18]   DAMNACANTHAL IS A HIGHLY POTENT, SELECTIVE INHIBITOR OF P56(LCK) TYROSINE KINASE-ACTIVITY [J].
FALTYNEK, CR ;
SCHROEDER, J ;
MAUVAIS, P ;
MILLER, D ;
WANG, S ;
MURPHY, D ;
LEHR, R ;
KELLEY, M ;
MAYCOCK, A ;
MICHNE, W ;
MISKI, M ;
THUNBERG, AL .
BIOCHEMISTRY, 1995, 34 (38) :12404-12410
[19]   The p53-dependent effects of macrophage migration inhibitory factor revealed by gene targeting [J].
Fingerle-Rowson, G ;
Petrenko, O ;
Metz, CN ;
Forsthuber, TG ;
Mitchell, R ;
Huss, R ;
Moll, U ;
Müller, W ;
Bucala, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (16) :9354-9359
[20]   Macrophage migration inhibitory factor, MIF alleles, and the genetics of inflammatory disorders: incorporating disease outcome into the definition of phenotype [J].
Gregersen, PK ;
Bucala, R .
ARTHRITIS AND RHEUMATISM, 2003, 48 (05) :1171-1176